SAN DIEGO, Sept. 29, 2014 /PRNewswire/ -- ResMed (NYSE:
RMD) today announced that it has expanded its relationship
with Brightree, the leading provider of home medical equipment
(HME) billing and business management software solutions. The two
companies have agreed to both enhance the existing integration of
ResMed's U-Sleep premium sleep compliance solution within the
Brightree solution and add new features and capabilities from
ResMed's AirView patient management system. The first of these
enhancements, scheduled to be introduced to joint customers in
November 2014, are designed to help
HME providers more cost effectively grow and manage their sleep
business. They will also give HMEs the flexibility to choose which
ResMed patient management system best suits their needs, U-Sleep or
AirView, both of which will be seamlessly accessible within the
Brightree solution.
In 2013, Brightree and ResMed began working together to automate
the onboarding of patients that use ResMed S9 positive airway
pressure devices into U-Sleep. The companies have continued to add
innovative capabilities that further automate HME workflows, such
as notifications in the Brightree system when a patient has reached
CMS compliance guidelines, and reporting patient use for audit
purposes or referral source education.
This next step, integrating U-Sleep and AirView into Brightree,
provides new and expanded capabilities. Key features soon to be
available to Brightree customers using ResMed devices include:
U-Sleep
- Support for ResMed's recently-launched AirSense 10 positive
airway pressure (PAP) devices, including patient boarding,
reporting, and compliance notifications
- Improvements to the patient boarding interface
- Access to additional reports and improved usability
AirView
- Access to therapy and compliance reports
- Ability to board a new patient directly from Brightree,
including the patient's referring physician
- Ability to "attach" to an existing patient record and store
patient details (including the patient start date) inside the
Brightree system
Support for ResMed's AirSense 10 series of positive airway
pressure devices will allow Brightree users to take advantage of
the ResMed HALO (Hour After Last Off) automatic data transmission
capability, delivering accelerated access to data within the
Brightree platform for patients using these devices.
"ResMed recognizes that many HME providers prefer to operate
their business from within a single application, and a significant
percentage of the industry uses Brightree as their business
platform of choice", said Raj Sodhi, Vice President, ResMed
Healthcare Informatics. "By expanding our integration with
Brightree, we will be able to advance our goal of seamlessly
delivering sleep and respiratory compliance management data and
features where and how our customers want to use them."
U-Sleep and AirView are part of the ResMed Air Solutions suite
of sleep and respiratory products that provide physicians,
providers, and patients with the tools and data they need to
improve workflow efficiencies and patient outcomes. This suite
includes the recently-announced AirSense 10 device series, which
can provide daily therapy information to AirView and U-Sleep via
built-in cellular communication.
About Brightree:
Brightree is the leading provider of cloud-based software to
improve clinical and business performance in the post-acute care
industry. The Company serves more than 3,000 organizations in the
home medical equipment (HME), home health, hospice, orthotic and
prosthetic (O&P), HME pharmacy, home infusion and rehab home
care segments. Brightree's solutions follow the natural workflow of
providers to automate and improve how they manage their businesses,
serve patients, and protect reimbursements. The company is ranked
as one of the top 100 healthcare IT companies in the U.S. on the
prestigious Healthcare Informatics 100 (HCI 100) list. For further
information, visit www.brightree.com or call 1-844-GET-BTRE
(438-2783).
Brightree is a registered trademark of Brightree LLC.
About ResMed:
ResMed changes lives by developing, manufacturing and
distributing medical equipment for treating, diagnosing, and
managing sleep-disordered breathing, COPD, and other chronic
diseases. We develop innovative products and solutions to improve
the health and quality of life of those who suffer from these
conditions, and we work to raise awareness of the potentially
serious health consequences of untreated sleep-disordered
breathing. For more information on ResMed, visit
www.resmed.com. For information on U-Sleep, visit
www.u-sleep.com.
Contacts:
|
|
For News
Media
|
For
Investors
|
Bernadette
McBrearty
|
Agnes Lee
|
Vice President,
Global Marketing Communications
|
Senior Director,
Investor Relations
|
O:
858-836-6786
|
O:
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
Logo -
http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
SOURCE ResMed Inc.